Exome-Seq of murine CT26 cell line - WT and gal-9-KO - in vitro
Ontology highlight
ABSTRACT: A number of studies have reported evidence of positive or negative contributions of galectin-9 (gal-9) to human and experimental malignancies. Some clinical observations and in vitro experiments suggest that cell-associated gal-9 has anti-metastatic effects. On the other hand, extra-cellular gal-9 consistently enhances tumor immune escape. The aim of this experiment is to study the impact of gal-9 gene invalidation in the colon carcinoma cell line CT26, in vitro. It complements the results of a RNAseq analysis carried out using the same cells, whose results are already available on Annotare (E-MTAB-9559)
INSTRUMENT(S): Illumina NovaSeq 6000
ORGANISM(S): Mus musculus
SUBMITTER: Pierre Busson
PROVIDER: E-MTAB-9837 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA